½ÃÀ庸°í¼­
»óǰÄÚµå
1595326

¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ±¸¼º¿ä¼Ò, ¹èÆ÷, ÃÖÁ¾ »ç¿ëÀÚ, Á¶Á÷ ±Ô¸ðº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Pharmacy Management System Market by Component (Services, Solution), Deployment (On-Cloud, On-Premise), End-User, Organization Size - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 235¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 269¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 14.79%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 617¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

¾à±¹ °ü¸® ½Ã½ºÅÛ(PMS)¿¡´Â ¾à±¹ ¿î¿µÀ» °£¼ÒÈ­ÇÏ°í ¼ÒºñÀÚ ¼­ºñ½º, Àç°í °ü¸® ¹× ±ÔÁ¤ Áؼö¸¦ °³¼±ÇÏ´Â ¼ÒÇÁÆ®¿þ¾î ¹× ±â¼ú ¼Ö·ç¼ÇÀÌ Æ÷ÇԵǸç, PMSÀÇ Çʿ伺Àº ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÀÖ¾î È¿À²ÀûÀÎ ¾à¹° °ü¸®, ¿À·ù °¨¼Ò ¹× ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹ß»ýÇß½À´Ï´Ù. Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. PMS´Â ¼Ò¸Å, º´¿ø, ¿ä¾ç ¾à±¹¿¡¼­ ó¹æÀü 󸮺ÎÅÍ Àç°í ÃßÀû, ÀÚµ¿ ¸®ÇʱîÁö ¸ðµç °ÍÀ» Áö¿øÇϸç, PMSÀÇ ÃÖÁ¾ ¿ëµµ´Â ´Ù¾çÇÑ ±Ô¸ðÀÇ ¾à±¹¿¡ Àû¿ëµÇ¸ç, ±¤¹üÀ§ÇÑ ÀÇ·á °ü¸® ½Ã½ºÅÛ¿¡ ¿øÈ°ÇÏ°Ô ÅëÇյǾî ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ³ëÀÎ Àα¸ Áõ°¡, ¸¸¼º ÁúȯÀÇ È®»ê, ÀÇ·á ºÐ¾ßÀÇ Å¬¶ó¿ìµå ÄÄÇ»ÆÃ, AI, ¸Ó½Å·¯´× µî ±â¼ú ¹ßÀüÀÌ ²ÅÈü´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¿öÅ©Ç÷οì È¿À²¼º Çâ»ó°ú ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù. ÃֽŠºñÁî´Ï½º ±âȸ´Â ¿ø°Ý ÀÇ·á ÅëÇÕ¿¡ ÀÖÀ¸¸ç, ¿ø°Ý ó¹æ ¹× ÁøÂûÀ» °¡´ÉÇÏ°Ô ÇÏ°í ¸ÂÃãÇü ÀǾàǰ °ü¸®¸¦ ÃËÁøÇÏ´Â °³ÀÎ ¸ÂÃãÇü ÀǷḦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇØ ½ÃÀå Âü¿©ÀÚµéÀº µ¥ÀÌÅÍ º¸¾ÈÀ» °­È­ÇÏ°í ±ÔÁ¦ Áؼö µµ±¸¿¡ ÅõÀÚÇÏ¿© º¸´Ù ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» ÃËÁøÇØ¾ß ÇÕ´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱ⠵µÀÔ ºñ¿ë, º¹ÀâÇÑ ±ÔÁ¦, ±âÁ¸ ÀÎÇÁ¶ó ¾÷±×·¹À̵åÀÇ Çʿ伺 µîÀÇ °úÁ¦µµ ³²¾ÆÀÖ½À´Ï´Ù. ÀÌ´Â ¼Ò±Ô¸ð ¾à±¹À̳ª °³¹ßµµ»ó±¹ÀÇ ¾à±¹µéÀÌ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» µµÀÔÇÏ´Â °ÍÀ» ÁÖÀúÇÏ°Ô ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ º¸´Ù Á÷°üÀûÀÎ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º °³¹ß, ¾ÈÀüÇÑ °Å·¡ ±â·ÏÀ» À§ÇÑ ºí·ÏüÀÎ, Àç°í ÆÐÅÏ ¹× ȯÀÚ ¼øÀÀµµ ¿¹Ãø ºÐ¼® µî Çõ½ÅÀÇ °¡´É¼ºÀº ¹«±Ã¹«ÁøÇÕ´Ï´Ù. ¶ÇÇÑ ±âÁ¸ ÀÇ·á ½Ã½ºÅÛ°úÀÇ »óÈ£ ¿î¿ë¼º ¹× ÀÇ»ç °áÁ¤ Áö¿øÀ» À§ÇÑ AI ±â´É Çâ»ó¿¡ ´ëÇÑ ¿¬±¸µµ °¡´ÉÇϸç, PMS ½ÃÀåÀÇ Æ¯¼ºÀº ±â¼ú Çõ½Å°ú µðÁöÅÐ Çコ »ýŰè·ÎÀÇ Àüȯ¿¡ µû¶ó ¿ªµ¿ÀûÀ¸·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ±â¼ú°ú ȯÀÚ Ä¡·á ÃÖÀûÈ­ÀÇ Á¢Á¡¿¡ À§Ä¡ÇÑ ±â¾÷ÀÌ °¡Àå ¼º°øÇÒ °¡´É¼ºÀÌ ³ôÀ¸¸ç, »ç¿ëÀÚ Çൿ, ±ÔÁ¦ »óȲ, »õ·Î¿î ±â¼ú¿¡ ´ëÇÑ ÅëÂû·ÂÀº »ç¾÷ÀÇ Áö¼ÓÀû ¼ºÀå¿¡ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 235¾ï ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 269¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 617¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 14.79%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®À» °ø°³ÇÕ´Ï´Ù.

¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àç°í °ü¸® °³¼±¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡
    • À§Á¶ ÀǾàǰ À§Çè Áõ°¡
    • Á¦¾à»ê¾÷ IT °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß ÅõÀÚ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • º¥´õ ¶ôÀÎ ¹®Á¦
  • ½ÃÀå ±âȸ
    • Çõ½ÅÀûÀÎ Á¦Ç° ¹× ¼Ö·ç¼Ç °³¹ß
    • Á¦¾à»ç¿Í IT ±â¾÷ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇÑ Á¦Ç° ¼­ºñ½º °³¼±
  • ½ÃÀå °úÁ¦
    • °¢±¹ÀÇ ±ÔÁ¦ »óȲÀÇ ¿Ï¸¸ÇÔ

Porter's Five Forces: ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå °ø·«À» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces: ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸³´Ï´Ù.

¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ, ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

    Á¦6Àå ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

    • ¼­·Ð
    • ¼­ºñ½º
    • ¼Ö·ç¼Ç
      • ÀÓ»ó ¹× °ü¸® ÆÛÆ÷¸Õ½º
      • Àç°í °ü¸®
      • ¹ßÁÖ °ü¸®
      • ±ÔÁ¦ ¹× ÄÄÇöóÀ̾𽺠Á¤º¸
      • °ø±Þ¸Á °ü¸®

    Á¦7Àå ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : Àü°³ Çüź°

    • ¼­·Ð
    • Ŭ¶ó¿ìµå
    • ¿ÂÇÁ·¹¹Ì½º

    Á¦8Àå ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

    • ¼­·Ð
    • º´¿ø
    • ¾à±¹

    Á¦9Àå ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : Á¶Á÷ ±Ô¸ðº°

    • ¼­·Ð
    • ´ë±Ô¸ð ¾à±¹
    • Áß¼Ò±Ô¸ð ¾à±¹

    Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå

    • ¼­·Ð
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
    • ¹Ì±¹

    Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå

    • ¼­·Ð
    • È£ÁÖ
    • Áß±¹
    • Àεµ
    • Àεµ³×½Ã¾Æ
    • ÀϺ»
    • ¸»·¹À̽þÆ
    • Çʸ®ÇÉ
    • ½Ì°¡Æ÷¸£
    • Çѱ¹
    • ´ë¸¸
    • ű¹
    • º£Æ®³²

    Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå

    • ¼­·Ð
    • µ§¸¶Å©
    • ÀÌÁýÆ®
    • Çɶõµå
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • À̽º¶ó¿¤
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ³ªÀÌÁö¸®¾Æ
    • ³ë¸£¿þÀÌ
    • Æú¶õµå
    • īŸ¸£
    • ·¯½Ã¾Æ
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ½ºÆäÀÎ
    • ½º¿þµ§
    • ½ºÀ§½º
    • ÅÍŰ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ¿µ±¹

    Á¦13Àå °æÀï ±¸µµ

    • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
    • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
    • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Àü·« ºÐ¼®°ú Á¦¾È

    ±â¾÷ ¸®½ºÆ®

    • Allscripts Healthcare, LLC
    • Becton, Dickinson and Company
    • Cerner Corporation
    • Clanwilliam Health Ltd.
    • DataScan Pharmacy
    • Epicor Software Corporation
    • GE Healthcare, Inc.
    • GlobeMed Ltd.
    • Health Business Systems Inc.
    • Intel Corporation
    • Liberty Software
    • McKesson Corporation
    • MedHOK Inc.
    • Octal IT Solution LLP
    • Omnicell Inc.
    • Talyst LLC
    LSH

    The Pharmacy Management System Market was valued at USD 23.50 billion in 2023, expected to reach USD 26.95 billion in 2024, and is projected to grow at a CAGR of 14.79%, to USD 61.72 billion by 2030.

    A Pharmacy Management System (PMS) encompasses the software and technology solutions that streamline pharmacy operations, improving consumer services, inventory management, and regulatory compliance. The necessity of PMS arises from the increasing demand for efficient medication management, error reduction, and patient safety in healthcare delivery. Application-wise, PMS is utilized in retail, hospital, and long-term care pharmacies, supporting everything from prescription processing to inventory tracking and automated refills. Its end-use scope spans pharmacies of various sizes, integrating seamlessly into wider healthcare management systems. Key growth influencers include the rising geriatric population, increasing chronic disease prevalence, and technological advancements such as cloud computing, AI, and machine learning in healthcare. The advancements drive demand for improved workflow efficiency and real-time data analytics. Latest opportunities lie in telehealth integration, enabling remote prescription fulfillment and consultations, and personalized medicine fostering custom pharmaceuticals management. To seize these, market players should invest in data security enhancements and regulatory compliance tools, facilitating broader adoption. However, challenges persist, including high initial implementation costs, regulatory complexities, and the need for upgrading existing infrastructure. These may deter smaller pharmacies or those in developing regions from adopting such systems. Innovation prospects are abundant, particularly in developing more intuitive user interfaces, blockchain for secure transaction records, and predictive analytics for stocking patterns and patient adherence. Research can also delve into interoperability with existing healthcare systems and improving AI capabilities for decision support. The nature of the PMS market is dynamically evolving, driven by technological innovation and a shift towards digital health ecosystems. Companies positioning themselves at the nexus of technology and patient care optimization are most likely to thrive, making insight into user behavior, regulatory landscapes, and emerging tech crucial for sustained business growth.

    KEY MARKET STATISTICS
    Base Year [2023] USD 23.50 billion
    Estimated Year [2024] USD 26.95 billion
    Forecast Year [2030] USD 61.72 billion
    CAGR (%) 14.79%

    Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmacy Management System Market

    The Pharmacy Management System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

    • Market Drivers
      • Increasing need to improve inventory management
      • Rising risk of counterfeit medicines
      • Investment in R&D towards the development of IT for the pharma industry
    • Market Restraints
      • Vendor lock-in issues
    • Market Opportunities
      • Development of innovative products and solutions
      • Strategic partnership between pharmaceutical and IT companies to improve the products and services
    • Market Challenges
      • Loosely defined regulatory landscape in countries

    Porter's Five Forces: A Strategic Tool for Navigating the Pharmacy Management System Market

    Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmacy Management System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

    PESTLE Analysis: Navigating External Influences in the Pharmacy Management System Market

    External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmacy Management System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

    Market Share Analysis: Understanding the Competitive Landscape in the Pharmacy Management System Market

    A detailed market share analysis in the Pharmacy Management System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

    FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmacy Management System Market

    The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmacy Management System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

    Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmacy Management System Market

    A strategic analysis of the Pharmacy Management System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

    Key Company Profiles

    The report delves into recent significant developments in the Pharmacy Management System Market, highlighting leading vendors and their innovative profiles. These include Allscripts Healthcare, LLC, Becton, Dickinson and Company, Cerner Corporation, Clanwilliam Health Ltd., DataScan Pharmacy, Epicor Software Corporation, GE Healthcare, Inc., GlobeMed Ltd., Health Business Systems Inc., Intel Corporation, Liberty Software, McKesson Corporation, MedHOK Inc., Octal IT Solution LLP, Omnicell Inc., and Talyst LLC.

    Market Segmentation & Coverage

    This research report categorizes the Pharmacy Management System Market to forecast the revenues and analyze trends in each of the following sub-markets:

    • Based on Component, market is studied across Services and Solution. The Solution is further studied across Clinical & Administrative Performance, Inventory Management, Purchase Orders Management, Regulatory & Compliance Information, and Supply Chain Management.
    • Based on Deployment, market is studied across On-Cloud and On-Premise.
    • Based on End-User, market is studied across Hospital and Pharmacy.
    • Based on Organization Size, market is studied across Large Pharmacy and Small & Medium-Sized Pharmacy.
    • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

    The report offers a comprehensive analysis of the market, covering key focus areas:

    1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

    2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

    3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

    4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

    5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

    The report also answers critical questions to aid stakeholders in making informed decisions:

    1. What is the current market size, and what is the forecasted growth?

    2. Which products, segments, and regions offer the best investment opportunities?

    3. What are the key technology trends and regulatory influences shaping the market?

    4. How do leading vendors rank in terms of market share and competitive positioning?

    5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

    Table of Contents

    1. Preface

    • 1.1. Objectives of the Study
    • 1.2. Market Segmentation & Coverage
    • 1.3. Years Considered for the Study
    • 1.4. Currency & Pricing
    • 1.5. Language
    • 1.6. Stakeholders

    2. Research Methodology

    • 2.1. Define: Research Objective
    • 2.2. Determine: Research Design
    • 2.3. Prepare: Research Instrument
    • 2.4. Collect: Data Source
    • 2.5. Analyze: Data Interpretation
    • 2.6. Formulate: Data Verification
    • 2.7. Publish: Research Report
    • 2.8. Repeat: Report Update

    3. Executive Summary

    4. Market Overview

    5. Market Insights

    • 5.1. Market Dynamics
      • 5.1.1. Drivers
        • 5.1.1.1. Increasing need to improve inventory management
        • 5.1.1.2. Rising risk of counterfeit medicines
        • 5.1.1.3. Investment in R&D towards the development of IT for the pharma industry
      • 5.1.2. Restraints
        • 5.1.2.1. Vendor lock-in issues
      • 5.1.3. Opportunities
        • 5.1.3.1. Development of innovative products and solutions
        • 5.1.3.2. Strategic partnership between pharmaceutical and IT companies to improve the products and services
      • 5.1.4. Challenges
        • 5.1.4.1. Loosely defined regulatory landscape in countries
    • 5.2. Market Segmentation Analysis
    • 5.3. Porter's Five Forces Analysis
      • 5.3.1. Threat of New Entrants
      • 5.3.2. Threat of Substitutes
      • 5.3.3. Bargaining Power of Customers
      • 5.3.4. Bargaining Power of Suppliers
      • 5.3.5. Industry Rivalry
    • 5.4. PESTLE Analysis
      • 5.4.1. Political
      • 5.4.2. Economic
      • 5.4.3. Social
      • 5.4.4. Technological
      • 5.4.5. Legal
      • 5.4.6. Environmental

    6. Pharmacy Management System Market, by Component

    • 6.1. Introduction
    • 6.2. Services
    • 6.3. Solution
      • 6.3.1. Clinical & Administrative Performance
      • 6.3.2. Inventory Management
      • 6.3.3. Purchase Orders Management
      • 6.3.4. Regulatory & Compliance Information
      • 6.3.5. Supply Chain Management

    7. Pharmacy Management System Market, by Deployment

    • 7.1. Introduction
    • 7.2. On-Cloud
    • 7.3. On-Premise

    8. Pharmacy Management System Market, by End-User

    • 8.1. Introduction
    • 8.2. Hospital
    • 8.3. Pharmacy

    9. Pharmacy Management System Market, by Organization Size

    • 9.1. Introduction
    • 9.2. Large Pharmacy
    • 9.3. Small & Medium-Sized Pharmacy

    10. Americas Pharmacy Management System Market

    • 10.1. Introduction
    • 10.2. Argentina
    • 10.3. Brazil
    • 10.4. Canada
    • 10.5. Mexico
    • 10.6. United States

    11. Asia-Pacific Pharmacy Management System Market

    • 11.1. Introduction
    • 11.2. Australia
    • 11.3. China
    • 11.4. India
    • 11.5. Indonesia
    • 11.6. Japan
    • 11.7. Malaysia
    • 11.8. Philippines
    • 11.9. Singapore
    • 11.10. South Korea
    • 11.11. Taiwan
    • 11.12. Thailand
    • 11.13. Vietnam

    12. Europe, Middle East & Africa Pharmacy Management System Market

    • 12.1. Introduction
    • 12.2. Denmark
    • 12.3. Egypt
    • 12.4. Finland
    • 12.5. France
    • 12.6. Germany
    • 12.7. Israel
    • 12.8. Italy
    • 12.9. Netherlands
    • 12.10. Nigeria
    • 12.11. Norway
    • 12.12. Poland
    • 12.13. Qatar
    • 12.14. Russia
    • 12.15. Saudi Arabia
    • 12.16. South Africa
    • 12.17. Spain
    • 12.18. Sweden
    • 12.19. Switzerland
    • 12.20. Turkey
    • 12.21. United Arab Emirates
    • 12.22. United Kingdom

    13. Competitive Landscape

    • 13.1. Market Share Analysis, 2023
    • 13.2. FPNV Positioning Matrix, 2023
    • 13.3. Competitive Scenario Analysis
    • 13.4. Strategy Analysis & Recommendation

    Companies Mentioned

    • 1. Allscripts Healthcare, LLC
    • 2. Becton, Dickinson and Company
    • 3. Cerner Corporation
    • 4. Clanwilliam Health Ltd.
    • 5. DataScan Pharmacy
    • 6. Epicor Software Corporation
    • 7. GE Healthcare, Inc.
    • 8. GlobeMed Ltd.
    • 9. Health Business Systems Inc.
    • 10. Intel Corporation
    • 11. Liberty Software
    • 12. McKesson Corporation
    • 13. MedHOK Inc.
    • 14. Octal IT Solution LLP
    • 15. Omnicell Inc.
    • 16. Talyst LLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦